These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 33605002)

  • 1. Botulinum toxin and platelet rich plasma as innovative therapeutic modalities for keloids.
    Neinaa YME; Elsayed TA; Mohamed DA; Elfar NN
    Dermatol Ther; 2021 May; 34(3):e14900. PubMed ID: 33605002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined intralesional triamcinolone acetonide and platelet rich plasma versus intralesional triamcinolone acetonide alone in treatment of keloids.
    Hewedy ES; Sabaa BEI; Mohamed WS; Hegab DS
    J Dermatolog Treat; 2022 Feb; 33(1):150-156. PubMed ID: 32063079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intralesional pentoxifylline, triamcinolone acetonide, and their combination for treatment of keloid scars.
    Serag-Eldin YMA; Mahmoud WH; Gamea MM; Hegab DS
    J Cosmet Dermatol; 2021 Oct; 20(10):3330-3340. PubMed ID: 34138506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The safety and efficacy of intralesional triamcinolone acetonide for keloids and hypertrophic scars: A systematic review and meta-analysis.
    Zhuang Z; Li Y; Wei X
    Burns; 2021 Aug; 47(5):987-998. PubMed ID: 33814214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of intralesional triamcinolone acetonide, botulinum toxin type A, and their combination for the treatment of keloid lesions.
    Gamil HD; Khattab FM; El Fawal MM; Eldeeb SE
    J Dermatolog Treat; 2020 Aug; 31(5):535-544. PubMed ID: 31184533
    [No Abstract]   [Full Text] [Related]  

  • 6. Assessment of intralesional injection of botulinum toxin type A in hypertrophic scars and keloids: Clinical and pathological study.
    Khatery BHM; Hussein HA; Abd-El-Raheem TA; El Hanbuli HM; Yassen NN
    Dermatol Ther; 2022 Oct; 35(10):e15748. PubMed ID: 36190006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Triple treatment in ear keloids: Comparison of post-excisional intralesional steroid and platelet-rich plasma treatment.
    Yıldız E
    Am J Otolaryngol; 2021; 42(3):102935. PubMed ID: 33545451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of a triamcinolone acetonide-loaded dissolving microneedle patch for the treatment of hypertrophic scars and keloids: a randomized, double-blinded, placebo-controlled split-scar study.
    Disphanurat W; Sivapornpan N; Srisantithum B; Leelawattanachai J
    Arch Dermatol Res; 2023 May; 315(4):989-997. PubMed ID: 36383222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of keloid scars with intralesional triamcinolone and 5-fluorouracil injections - a randomized controlled trial.
    Hietanen KE; Järvinen TA; Huhtala H; Tolonen TT; Kuokkanen HO; Kaartinen IS
    J Plast Reconstr Aesthet Surg; 2019 Jan; 72(1):4-11. PubMed ID: 30448246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recurrence rates in the treatment of keloids and hypertrophic scars with intralesional triamcinolone combined with other intralesional agents.
    Rimmer SN; Chandy RJ; Khan D; Feldman SR
    Arch Dermatol Res; 2023 Dec; 315(10):2757-2767. PubMed ID: 37432467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical effects of pulsed dye laser dynamically combined with triamcinolone acetonide in the treatment of keloids].
    Liu ZN; Zhou YM; Liu RX; Li YL; Li Q; Zhang T; Zhang SM
    Zhonghua Shao Shang Yu Chuang Mian Xiu Fu Za Zhi; 2022 Sep; 38(9):822-829. PubMed ID: 36177586
    [No Abstract]   [Full Text] [Related]  

  • 12. Efficacy and safety of verapamil vs triamcinolone acetonide for keloids and hypertrophic scars: A systematic review and meta-analysis.
    Liu R; Yang B; Deng Z; Liu L; Zhao X
    Dermatol Ther; 2020 Jul; 33(4):e13564. PubMed ID: 32400925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative evaluation of therapeutic efficacy and safety of intralesional triamcinolone acetonide injection vs intralesional radiofrequency with intralesional triamcinolone acetonide in treatment of keloids.
    Kaushal V; Kumar S; Brar BK; Singh A
    Dermatol Ther; 2020 Nov; 33(6):e13919. PubMed ID: 32594600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and efficacy of intralesional injection of enalapril versus triamcinolone acetonide in the treatment of keloids.
    Hamada Mohamed B; Eltahlawy S; Marzouk WA; Mohamad NE
    Acta Dermatovenerol Alp Pannonica Adriat; 2023 Sep; 32(3):77-81. PubMed ID: 37749966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of various intralesional injections in keloid: comparative analysis.
    Albalat W; Nabil S; Khattab F
    J Dermatolog Treat; 2022 Jun; 33(4):2051-2056. PubMed ID: 33849382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative efficacy of intralesional verapamil hydrochloride and triamcinolone acetonide in hypertrophic scars and keloids.
    Ahuja RB; Chatterjee P
    Burns; 2014 Jun; 40(4):583-8. PubMed ID: 24182692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of laser-assisted delivery vs intralesional injection of botulinum toxin A in treatment of hypertrophic scars and keloids.
    Sabry HH; Ibrahim EA; Hamed AM
    Dermatol Ther; 2020 Nov; 33(6):e13980. PubMed ID: 32638463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of Small Keloids Using Intralesional 5-fluorouracil and Triamcinolone Acetonide versus Intralesional Bleomycin and Triamcinolone Acetonide.
    Sharma S; Vinay K; Bassi R
    J Clin Aesthet Dermatol; 2021 Mar; 14(3):17-21. PubMed ID: 33841611
    [No Abstract]   [Full Text] [Related]  

  • 19. Botulinum toxin type A versus 5-Fluorouracil in treatment of keloid.
    Ismail SA; Mohammed NHK; Sotohy M; Abou-Taleb DAE
    Arch Dermatol Res; 2021 Sep; 313(7):549-556. PubMed ID: 32892246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intralesional triamcinolone alone or in combination with botulinium toxin A is ineffective for the treatment of formed keloid scar: A double blind controlled pilot study.
    Rasaii S; Sohrabian N; Gianfaldoni S; Hadibarhaghtalab M; Pazyar N; Bakhshaeekia A; Lotti T; Ramirez-Pacheco LA; Lange CS; Matta J; Seifi V; Ramirez-Fort MK; Feily A
    Dermatol Ther; 2019 Mar; 32(2):e12781. PubMed ID: 30422367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.